Levemir is critical for young people and pregnant women, patients say. But it won’t be sold in the U.S. after this year.
Big Pharma
Posted inTAP
Drug Companies Are Fighting Biden’s Efforts to Lower Their Prices
Today on TAP: We should visibly fight back (good for Americans’ health and wallets, and good for Democrats’ prospects).
Posted inHealth and Social Policy
‘Return What You Stole and Be a Man With Dignity’
Doctors didn’t think it was possible to loathe the world’s biggest health care profiteer any more. Then came the hack that set half their bookkeeping systems on fire.
Posted inHealth and Social Policy
Zoomer Hackers Shut Down the Biggest Extortion Ring of All
A ransomware gang cripples UnitedHealthcare. Could a comprehensive antitrust investigation finish the job?
Posted inHealth and Social Policy
Bernie Sanders Isn’t Thankful for High Drug Prices
Another in a series of hearings with pharma CEOs takes place today.
Posted inHealth and Social Policy
Public Pharma’s Biggest Barrier
California is about to start developing and manufacturing insulin. But is the state too tied up with nonprofit Civica Rx, rather than building its own capacity?
Posted inTAP
The Insulin Shift
Today on TAP: Thanks to Democrats and the American Rescue Plan, insulin prices are going way down for everyone.
Posted inMoney, Politics, and Power
American Kleptocracy Revisited
Our investigative editor’s favorites for 2023
